{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:04:47Z","timestamp":1793883887147,"version":"4.7.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","award":["CRI4503"],"award-info":[{"award-number":["CRI4503"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016580","name":"Kennedy Trust for Rheumatology Research","doi-asserted-by":"publisher","award":["202117"],"award-info":[{"award-number":["202117"]}],"id":[{"id":"10.13039\/100016580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["100262Z\/12\/Z"],"award-info":[{"award-number":["100262Z\/12\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224343\/Z\/21\/Z."],"award-info":[{"award-number":["224343\/Z\/21\/Z."]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R37 AI043542"],"award-info":[{"award-number":["R37 AI043542"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaut.2025.103456","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:10:43Z","timestamp":1751447443000},"page":"103456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["STAT3 phosphorylation in the rheumatoid arthritis immunological synapse"],"prefix":"10.1016","volume":"155","author":[{"given":"Hila","family":"Novak-Kotzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8123-7725","authenticated-orcid":false,"given":"Jesusa","family":"Capera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Jainarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirudula","family":"Elanchezhian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Valvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viveka","family":"Mayya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Zanin-Zhorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Dustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jaut.2025.103456_bib1","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ng.479","article-title":"Genetic variants at CD28, PRDM1 and CD2\/CD58 are associated with rheumatoid arthritis risk","volume":"41","author":"Raychaudhuri","year":"2009","journal-title":"Nat. Genet."},{"issue":"Suppl 3","key":"10.1016\/j.jaut.2025.103456_bib2","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1186\/ar559","article-title":"The immunological synapse","volume":"4","author":"Dustin","year":"2002","journal-title":"Arthritis Res."},{"issue":"7639","key":"10.1016\/j.jaut.2025.103456_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13073-018-0575-9","article-title":"Increased DNA methylation variability in rheumatoid arthritis-discordant monozygotic twins","volume":"10","author":"Webster","year":"2018","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0105-2896.2009.00850.x","article-title":"Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis","volume":"233","author":"Wegner","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2025.103456_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"10.1016\/j.jaut.2025.103456_bib7","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/ard.2008.101121","article-title":"Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors","volume":"68","author":"Westhovens","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jaut.2025.103456_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.immuni.2006.03.001","article-title":"CTLA4Ig: bridging the basic immunology with clinical application","volume":"24","author":"Bluestone","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2025.103456_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(16)00380-9","article-title":"Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial","volume":"388","author":"Porter","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jaut.2025.103456_bib10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/annrheumdis-2013-203993","article-title":"Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study","volume":"74","author":"Emery","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"9194","key":"10.1016\/j.jaut.2025.103456_bib11","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT study group","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/annrheumdis-2015-207281","article-title":"Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)","volume":"75","author":"Burmester","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.jaut.2025.103456_bib13","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2008.092932","article-title":"IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial","volume":"67","author":"Emery","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"9877","key":"10.1016\/j.jaut.2025.103456_bib14","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(13)60250-0","article-title":"Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial","volume":"381","author":"Gabay","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2025.103456_bib15","first-page":"343","article-title":"Biological therapies for rheumatoid arthritis: an overview for the clinician","volume":"15","author":"Findeisen","year":"2021","journal-title":"Biologics"},{"issue":"7","key":"10.1016\/j.jaut.2025.103456_bib16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/annrheumdis-2020-219214","article-title":"Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial","volume":"80","author":"Combe","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103456_bib17","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0140-6736(19)30419-2","article-title":"Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study","volume":"393","author":"Smolen","year":"2019","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.jaut.2025.103456_bib18","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa2008250","article-title":"Trial of upadacitinib or abatacept in rheumatoid arthritis","volume":"383","author":"Rubbert-Roth","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jaut.2025.103456_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","volume":"18","author":"Tanaka","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103456_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O'Shea","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.jaut.2025.103456_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0898-6568(99)00045-5","article-title":"The Src-family kinase LCK can induce STAT3 phosphorylation and DNA binding activity","volume":"11","author":"Lund","year":"1999","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.182.1.613","article-title":"Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis","volume":"182","author":"Nowell","year":"2009","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.jaut.2025.103456_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137385","article-title":"Constitutive STAT3 phosphorylation in circulating CD4+ T lymphocytes associates with disease activity and treatment response in recent-onset rheumatoid arthritis","volume":"10","author":"Kuuliala","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jaut.2025.103456_bib24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/rheumatology\/keu430","article-title":"The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels","volume":"54","author":"Isomaki","year":"2015","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11233-w","article-title":"Stat3 as a potential therapeutic target for rheumatoid arthritis","volume":"7","author":"Oike","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2025.103456_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47528","article-title":"Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells","volume":"8","author":"Saliba","year":"2019","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib27","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1038\/s41467-019-12464-3","article-title":"Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease","volume":"10","author":"Szabo","year":"2019","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.jaut.2025.103456_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160964","article-title":"Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide\/calcitriol liposomes in ACPA+ rheumatoid arthritis","volume":"7","author":"Sonigra","year":"2022","journal-title":"JCI Insight"},{"issue":"7490","key":"10.1016\/j.jaut.2025.103456_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature12951","article-title":"Polarized release of T cell-receptor-enriched microvesicles at the immunological synapse","volume":"507","author":"Choudhuri","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.immuni.2006.04.010","article-title":"T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster","volume":"25","author":"Varma","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2025.103456_bib31","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03180","article-title":"CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection","volume":"3","author":"Linterman","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.jaut.2025.103456_bib32","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.3389\/fimmu.2018.02864","article-title":"TCR and CD28 concomitant stimulation elicits a distinctive calcium response in naive T cells","volume":"9","author":"Xia","year":"2018","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.jaut.2025.103456_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275987","article-title":"The lymphocyte-specific protein tyrosine kinase-specific inhibitor A-770041 attenuates lung fibrosis via the suppression of TGF-beta production in regulatory T cells","volume":"17","author":"Kagawa","year":"2022","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jaut.2025.103456_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102663","article-title":"Role of the membrane anchor in the regulation of LCK activity","volume":"298","author":"Porciello","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/jpet.105.089169","article-title":"A-770041, a novel and selective small-molecule inhibitor of LCK, prevents heart allograft rejection","volume":"315","author":"Stachlewitz","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002671","article-title":"JAK inhibitors disrupt T cell-induced proinflammatory macrophage activation","volume":"9","author":"Nyirenda","year":"2023","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.jaut.2025.103456_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106324","article-title":"Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T cells","volume":"26","author":"Jainarayanan","year":"2023","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.jaut.2025.103456_bib38","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/rheumatology\/kez003","article-title":"Expression of STAT3-regulated genes in circulating CD4+ T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritis","volume":"58","author":"Anderson","year":"2019","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jaut.2025.103456_bib39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1634\/stemcells.19-5-378","article-title":"SOCS proteins: negative regulators of cytokine signaling","volume":"19","author":"Krebs","year":"2001","journal-title":"Stem Cell."},{"issue":"11","key":"10.1016\/j.jaut.2025.103456_bib40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0898-6568(99)00045-5","article-title":"The src-family kinase LCK can induce STAT3 phosphorylation and DNA binding activity","volume":"11","author":"Lund","year":"1999","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.jaut.2025.103456_bib41","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.4049\/jimmunol.163.4.1742","article-title":"Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells","volume":"163","author":"Gerwien","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2025.103456_bib42","first-page":"2024","article-title":"Synaptic synergy of T cell receptor and interleukin 2 receptor in CD8+ T cells","author":"Capera","year":"2024","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.jaut.2025.103456_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2006.06.015","article-title":"CXCR4 physically associates with the T cell receptor to signal in T cells","volume":"25","author":"Kumar","year":"2006","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.jaut.2025.103456_bib44","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1074\/jbc.M408481200","article-title":"Identification of the cytoplasmic domains of CXCR4 involved in Jak2 and STAT3 phosphorylation","volume":"280","author":"Ahr","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2025.103456_bib45","article-title":"Single-molecule, super-resolution, and functional analysis of G protein-coupled receptor behavior within the T cell immunological synapse","volume":"8","author":"Felce","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103456_bib46","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230683","article-title":"TCR signaling induces STAT3 phosphorylation to promote TH17 cell differentiation","volume":"221","author":"Qin","year":"2024","journal-title":"J. Exp. Med."},{"issue":"19","key":"10.1016\/j.jaut.2025.103456_bib47","doi-asserted-by":"crossref","first-page":"16777","DOI":"10.1074\/jbc.M207999200","article-title":"Constitutive STAT3 activation in intestinal T cells from patients with crohn's disease","volume":"278","author":"Lovato","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13075-015-0590-9","article-title":"CD4 T cell transcriptome analysis reveals aberrant regulation of STAT3 and Wnt signaling pathways in rheumatoid arthritis: evidence from a case-control study","volume":"17","author":"Ye","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-018-1105-9","article-title":"Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients","volume":"15","author":"Canto","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.jaut.2025.103456_bib50","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/annrheumdis-2014-205850","article-title":"IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis","volume":"75","author":"Anderson","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"37","key":"10.1016\/j.jaut.2025.103456_bib51","doi-asserted-by":"crossref","first-page":"18517","DOI":"10.1073\/pnas.1904271116","article-title":"Reporters of TCR signaling identify arthritogenic T cells in murine and human autoimmune arthritis","volume":"116","author":"Ashouri","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2025.103456_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104497","article-title":"Role of biological agents in treatment of rheumatoid arthritis","volume":"150","author":"Law","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"5220","key":"10.1016\/j.jaut.2025.103456_bib53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.7541555","article-title":"Enhanced DNA-binding activity of a Stat3-Related protein in cells transformed by the src oncoprotein","volume":"269","author":"Yu","year":"1995","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jaut.2025.103456_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082197","article-title":"Cancer risk in patients treated with the JAK inhibitor tofacitinib: systematic review and meta-analysis","volume":"15","author":"Bezzio","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/kead163","article-title":"Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study","volume":"63","author":"Westermann","year":"2024","journal-title":"Rheumatology"},{"issue":"604","key":"10.1016\/j.jaut.2025.103456_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaw8151","article-title":"CD45 functions as a signaling gatekeeper in T cells","volume":"12","author":"Courtney","year":"2019","journal-title":"Sci. Signal."},{"issue":"6818","key":"10.1016\/j.jaut.2025.103456_bib57","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35053086","article-title":"CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling","volume":"409","author":"Irie-Sasaki","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jaut.2025.103456_bib58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar2528","article-title":"Antigen receptor signaling in the rheumatic diseases","volume":"11","author":"Zikherman","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.jaut.2025.103456_bib59","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/eji.1830250612","article-title":"Altered T lymphocyte signaling in rheumatoid arthritis","volume":"25","author":"Allen","year":"1995","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103456_bib60","first-page":"520","article-title":"Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood","volume":"59","author":"Combe","year":"1985","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103456_bib61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/icb.2012.4","article-title":"T cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man","volume":"90","author":"Sakaguchi","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103456_bib62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/intimm\/13.3.305","article-title":"A potential role for protein tyrosine kinase p56(lck) in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness","volume":"13","author":"Romagnoli","year":"2001","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2025.103456_bib63","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.4049\/jimmunol.159.6.2973","article-title":"Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis","volume":"159","author":"Maurice","year":"1997","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103456_bib64","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/MCB.22.2.400-411.2002","article-title":"Effect of redox balance alterations on cellular localization of LAT and downstream T cell receptor signaling pathways","volume":"22","author":"Gringhuis","year":"2002","journal-title":"Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.jaut.2025.103456_bib65","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/annrheumdis-2011-200968","article-title":"A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease","volume":"71","author":"Pratt","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103456_bib66","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3389\/fimmu.2019.01535","article-title":"IL-6 mediated transcriptional programming of naive CD4+ T cells in early rheumatoid arthritis drives dysregulated effector function","volume":"10","author":"Ridgley","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:17:14Z","timestamp":1776917834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841125001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":66,"alternative-id":["S0896841125001015"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103456","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT3 phosphorylation in the rheumatoid arthritis immunological synapse","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103456"}}